Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform

Financing includes Laronde founder, Flagship Pioneering, as well as a wide group of public and private investors Capital infusion will enable the build out of Laronde's Endless RNA technology platform and large-scale development capabilities, advancing ... Biopharmaceuticals, Venture Capital Laronde, Endless RNA
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news